Clinical Trial Update: Retrospective, Non-interventional Study of Depo-Eligard®.

View source ↗

Summary

A retrospective, non-interventional study evaluating Depo-Eligard for prostate cancer has completed, sponsored by Astellas Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Depo-Eligard (leuprolide acetate (depot formulation))

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostate Cancer | Status: COMPLETED